|Bid||6.43 x 1300|
|Ask||6.42 x 1000|
|Day's Range||6.28 - 6.44|
|52 Week Range||2.42 - 6.57|
|Beta (3Y Monthly)||2.50|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
The allure of investing in marijuana penny stocks can be very strong. Every investor has dreams of investing a couple thousand dollars in a penny stock, watching it go to $100 per share, and making millions of dollars. I know that I sure do.Even more tempting are penny stocks of companies that are in the marijuana industry. In this rapidly boom industry, it seems reasonable to assume that there are some hidden gems out there.But you need to be careful when investing in low prices stocks because most of these companies will not survive. After all, there is a reason why they trade at such low prices.InvestorPlace - Stock Market News, Stock Advice & Trading Tips * 7 Defense Stocks to Buy to Fortify Your Portfolio The following seven marijuana penny stocks are worth considering for different reasons. These are not recommendations. I just want to give you some insights to help you make a decisions. Emerald Health Therapeutics Inc. (EMHTF) Click to EnlargeEmerald Health Therapeutics (OTCMKTS:EMHTF) is a pharmaceutical company that produces and sells cannabis products.I think that there will soon be a price war in the cannabis industry. That is because investors are starting to realize that the costs savings of growing cannabis outside outweigh any benefits that growing indoors or in greenhouses.The large growers like Tilray (NASDAQ:TLRY), Cronos (NASDAQ:CRON), Aphria (NYSE:APHA) and Aurora (NYSE:ACB) primarily grow indoors or in greenhouses. They may have difficult time competing with the outdoors growers that can offer their customers much lower prices.Emerald Health grows in greenhouses but they are moving into outdoor growing. The company just received it cultivation license from Health Canada for a 12-acre outside grow area. This early move into outside growing could be a very bullish dynamic.Technically, this could be a logical place to buy EMHTF. It is a level that was support in December. It is also very oversold. 48North Cannabis Corp (NRTH) Click to Enlarge48North Cannabis Corp (TSE:NRTH) grows and sells medical marijuana.NRTH is also moving towards outdoor growing. The company announced last week that it successfully completed the planting of its first outdoor cannabis crop. This was at their 100-acre farm in Bryant County, Ont.This farm has 3.7 million square feet of growing space and the ability to yield over 100,000 pounds per harvest. That's a lot of weed. And its organic.I think that in addition to the cost savings, outdoor growing may have two other advantages as well. Some marijuana aficionados say that the best marijuana is grown in natural sunlight, so there may be an advantage in quality. * 7 Stocks to Buy This Summer Earnings Season The second advantage could be that growing in natural sunlight is socially conscious. The indoor growers need a tremendous amount of electricity for their operations and that results in pollution. Many customers of this industry are very concerned about climate change so this may affect their buying decisions. Cannabix Technologies Inc. (BLOZF) Click to EnlargeCannabix Technologies Inc. (OTCMKTS:BLOZF) develops and manufactures marijuana breathalyzers for the police. The stock symbol is pretty cool. BLOZ which is pronounced as blows. The F is added because it is a foreign company.I like idea behind Cannabix but I am not so sure that its future prospects are good. Unfortunately for BLOZF shareholders, the company has not turned a profit in the past 5 years. The stock just broke support at the 80 cents level. This level will now probably become a resistance level.Support becomes resistance because people who bought the stock at 80 cents are now losing money. They tell themselves that if it rallies back to 80, they will sell it. This sell interest creates the resistance level. Medipharm Labs Corp. (MEDIF) Click to EnlargeMedipharm Labs Corp. (OTCMKTS:MEDIF) is a medical cannabis company that focuses on downstream extraction and purification technologies.This company caught my attention due to the increased trading volume. This shows that maybe some of the bigger Walls Street funds or investors are getting involved.Medipharm just announced that it is moving from the Toronto Venture Exchange to the Toronto Stock Exchange. When a company moves its stock what is considered a higher tier exchange, such as in this case, it means that it will have more transparency and will make more disclosures. * 10 High-Flying, Overvalued Stocks in Danger of Crashing This is typically considered a bullish development for a company. Being on a higher tiered exchange gives it more credibility and makes it more appealing to investors. Neptune Wellness Solutions Inc. (NEPT) Click to EnlargeNeptune Wellness Solutions Inc. (NASDAQ:NEPT) engages in the extraction, purification, and formulation of cannabis products. This company caught my attention because it has been trending higher all year. Then yesterday, some positive news hit the tape.NEPT raised $41 million in a private placement. This means they issued new shares to private institutional investors in exchange for the cash. Shareholders must believe this is great news because the stock was up over 10% yesterday.Two Wall Street firms follow NEPT and they each have buy ratings on it. The average target price is $8.50. Valens Groworks Corp. (VGWCF) Click to EnlargeValens Groworks Corp. (OTCMKTS:VGWCF) is a biotechnology company that provides products which are developed from proprietary extraction techniques.This company has been trending higher since the beginning of the year. On July 15th, it released its second-quarter results. These showed that the company has made some significant improvements.Revenue increased to $8.8 million CAD. This was a 296% increase from the first quarter. Gross profit was $5.1 million CAD, which was 58% of revenue as compared to 38% for the first quarter. * 7 Defense Stocks to Buy to Fortify Your Portfolio Wall Street is very bullish on this stock. 4 firms follow it and they all have it rated as a buy. The average price target is $8.20, which is about 150% higher than current levels. PAO Group Inc. (PAOG) Click to EnlargePAO Group Inc. (OTCMKTS:PAOG) is a holding company which is dedicated to alternative patient care treatments.I have included this company to illustrate how some advertising in the financial media can be extremely mislead if not downright fraudulent.I am sure you have seen adds touting the recent alleged great performance of this or that recent recommendation. Ads that say thing like "this stock doubled" or "this stock is up 1,000%" are everywhere. Even though some of these headlines may technically be correct they can also be very misleading.For example, every stock has a bid and an offer. The bid is the highest price someone will pay for it and the offer is the lowest price someone will sell it for.Suppose a penny stock has a bid of 1 cent and an offer of 2 cents. If is someone sells it the last trade will be 1 cent. Then suppose some buys it. Now the last trade is 2 cents. The price has doubled, but the stock hasn't moved!Take a look at the PAOG price scale on the chart. This stock trades not in pennies but in ten thousandths of a penny. It could rise 1000% from 24 ten thousands to 240 ten thousandths. But there is no way you can make money. The trading costs would make it impossible to profit.So be careful when you see advertisements promoting supposed great returns. These returns may just be trading anomalies to are impossible to profit from.As of this writing the author held no positions in the aforementioned securities. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 7 Defense Stocks to Buy to Fortify Your Portfolio * 10 High-Flying, Overvalued Stocks in Danger of Crashing * 8 Stocks to Buy That Are Growing Faster Than Amazon The post 7 Marijuana Penny Stocks to Consider for Those Who Can Handle Risk appeared first on InvestorPlace.
Cannabis company Neptune Wellness Solutions Inc. (NASDAQ: NEPT) (TSX: NEPT) said Thursday it has completed a private placement delivering gross proceeds to the company of $41.4 million. Both existing and new institutional investors participated, led by Perceptive Advisors. Upon closing, Neptune issued a total of 9.42 million common shares with a purchase price of $4.40 per share.
LAVAL, QC, July 18, 2019 /PRNewswire/ - Neptune Wellness Solutions Inc. ("Neptune" or the "Company") (NEPT) (NEPT), a North American leader in cannabinoids extraction, formulation and turnkey packaging solutions, has completed a private placement with both existing and new institutional investors, led by Perceptive Advisors, resulting in gross proceeds to the Company of US$41.4 million ("The Offering"). John Moretz, Chairman of the Board, and Michael Cammarata, President and CEO of Neptune, invested US$5.0 million in the aggregate as part of this Offering.
Wellness and CBD brand Kaleidoscope Labs has raised a $4 million seed round support their expansion efforts. New York-based venture capital firm RRE Ventures led the round with participation from Barry Rosenstein, founder of JANA Partners. SOL Global Investments (CSE: SOL) (OTCQB: SOLCF) (Frankfurt: 9SB) has completed a $50 million private placement financing by way of the […]The post Cannabis Stock News Daily Roundup July 9 appeared first on Market Exclusive.
Neptune Wellness Solutions Inc. said Monday Chief Executive Jim Hamilton has stepped down after more than 4 years in the role, but will remain with the cannabis extraction company as an advisor. Neptune named Micheal Cammarata as its new CEO, effective Monday. The company said Cammarata, who has been a "serial entrepreneur" over the past 20 years, is the co-founder of wellness brand Schmidt's Naturals, which is now a business unit of Unilever PLC . "[Cammarata] has identified new trends and opportunities which led to the development of market-leading products," said Chairman John Moretz. "These critical skills should benefit our customers. Moreover, Michael possesses the right mix of operational CEO experience, leadership skills, and technology industry expertise to help elevate Neptune to the next level." Neptune's stock, which was still inactive in premarket trading, has soared 74.4% year to date, while the ETFMG Alternative Harvest ETF has rallied 27.3% and the Dow Jones Industrial Average has gained 15.4%.
After over 4 years, Jim Hamilton has stepped down from his role as CEO and Director but will remain as an advisor to the Board. Over the past 20 years, Mr. Cammarata has been a serial entrepreneur, developing businesses and successfully investing in various sectors such as wellness products, biotechnology, advertising, electronics and entertainment, through his own venture capital and private equity firm, Random Occurrence. Mr. Cammarata is the co-founder of Schmidt's Naturals, now a business unit of Unilever, which has quickly established itself as one of the fastest growing wellness brands. Mr. Cammarata's investment, strategic retail partnerships and deep understanding of digital architecture contributed to breakthrough years for Schmidt's Naturals' from its start-up stage in 2015 to the acquisition by Unilever in 2017.
This marijuana stock continues extracting more money from investors thanks to 2019 extraction deals with Tilray and The Green Organic Dutchman.
These cannabis stocks racked up gains of at least 60% in the first half of 2019. Which ones are most likely to keep the momentum going?
Medicare for all may not be just a Democratic talking point as the 2020 campaign kicks into high gear. It could also “dramatically” increase access to medical marijuana, according to Nicholas Vita, CEO of cannabis company Columbia Care.
Some of those may have gained their wealth through the Evolve Marijuana ETF (TSE:SEED) (OTC: EVVLF), which, in the last year, has delivered the best performance among all cannabis ETFs. Need more cannabis news? Evolve launched SEED on the Toronto Stock Exchange roughly 14 months ago.
Neptune Wellness Solutions (NASDAQ: NEPT) (TSX: NEPT) has reported that its subsidiary 9354-7537 Québec has received approval from Health Canada for its cannabis operations. Extraction Capacity Increases to 200,000 kg The scope of the amendment received from Health Canada permits expansion of cannabis operation areas to include an additional extraction room where Neptune will perform cold […]The post Neptune Gets Approval for Expansion of Cannabis Oil Capsule Production appeared first on Market Exclusive.
LAVAL, QC, June 17, 2019 /PRNewswire/ - Neptune Wellness Solutions Inc. ("Neptune" or the "Company") (NEPT) (NEPT) is pleased to announce that its wholly owned subsidiary, 9354-7537 Québec Inc., has received a notification letter from Health Canada indicating that all requested license amendments have been approved. The scope of the amendment received from Health Canada permits expansion of cannabis operation areas to include an additional extraction room where Neptune will perform cold ethanol extraction. Ethanol extraction is faster and more cost effective than the CO2 extraction currently used and will increase Neptune's input capacity from 30,000 kg to 200,000 kg.
Initiates Expansion of Extraction Capacity to 1,500,000 kg Along With Additional Packaging and Finished Forms Capabilities Creates a One-Stop Shop for Licenced Cannabis Producers Fiscal Year 2019 and Fourth ...
Shares of Neptune Wellness Solutions Inc. rallied Wednesday, after the Canada-based company announced a second 3-year extraction agreement with a cannabis company in a week.
NEW YORK, NY / ACCESSWIRE / June 12, 2019 / Neptune Wellness Solutions, Inc. (NASDAQ: NEPT ) will be discussing their earnings results in their 2019 Fourth Quarter Earnings to be held on June 12, 2019 ...